JEAN KANIDIS: Open Payments
NPI 1639353410 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,327 in 139 payments from 21 companies in 2025. Trend: 2023 $2,284 · 2024 $2,880 · 2025 $3,327
Food & beverage: $3,327
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $1,090 |
| Novo Nordisk Inc | 13 | $370 |
| Lilly USA, LLC | 13 | $282 |
| PFIZER INC. | 19 | $264 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $237 |
| ABBVIE INC. | 13 | $207 |
| Esperion Therapeutics, Inc. | 10 | $180 |
| Phathom Pharmaceuticals, Inc. | 6 | $121 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
Products named: AIRSUPRA, Wegovy, FARXIGA, Kerendia, NURTEC ODT, BREZTRI, MOUNJARO, NEXLETOL.
Industry payments across FL — which companies pay providers there.
